Goldman Sachs cuts Regenxbio target to $10

Goldman Sachs cuts Regenxbio (NASDAQ:RGNX) price target to $10 from $12 on RGX-202 regulatory uncertainty. Stock down 41% to $6.25.

ByChloe Hall- Senior Editor

Today / 09:54|Last updated: Today / 09:55

Goldman Sachs cuts Regenxbio target to $10 — Photo: Prepared by Bond.az

Goldman Sachs has lowered its price target on Regenxbio (NASDAQ:RGNX) to $10 from $12, maintaining a Neutral rating. The stock has plunged 41% over the past week to $6.25, near its 52-week low.

The move comes amid regulatory uncertainty for RGX-202, with the company planning to file in early 2027. Analyst Paul Choi noted Q1 2026 results and an operational update.

Investors are questioning the regulatory setup for RGX-202 after topline data. Goldman awaits interim NSAA updates and wAMD topline data.

Two key catalysts identified: AFFINITY interim NSAA results over 2026, and topline data for ABBV-RGX-314 (with AbbVie) in Q4 2026 for wAMD.

According to Bond.az analysis, the stock appears undervalued with a Fair Value of $11.70.

More News

Wolfe Research Boosts AMAT Target to $550

Today / 10:42

838

Wolfe Research Boosts AMAT Target to $550

Wolfe Research raised Applied Materials price target to $550 from $500, citing strong guidance and revenue growth. Shares have gained 154% in the past year.

ANALYST RATINGS →

Today / 10:03

707

Citizens Reiterates Uber Stock Rating on EBITDA

Citizens reiterates Market Outperform rating on Uber with $100 target, citing EBITDA growth and autonomous vehicle potential.

ANALYST RATINGS →

Jefferies Raises AMAT Target to $510 on AI

Today / 10:02

797

Jefferies Raises AMAT Target to $510 on AI

Jefferies raises Applied Materials price target to $510, citing AI growth and strong semiconductor outlook.

ANALYST RATINGS →

Today / 10:01

662

Citizens Reiterates Charles Schwab Stock Rating

Citizens maintains Market Outperform rating on Charles Schwab with $120 price target after investor day. AI viewed as net positive.

ANALYST RATINGS →

BofA hikes Applied Materials target to $540

Today / 10:00

634

BofA hikes Applied Materials target to $540

BofA raises Applied Materials price target to $540 from $465, citing strong outlook and record quarterly results.

ANALYST RATINGS →

Citizens Raises Bandwidth Stock Price Target

Today / 09:53

570

Citizens Raises Bandwidth Stock Price Target

Citizens raises Bandwidth price target to $70 from $45, citing AI voice opportunity and Salesforce selection. Stock up 257% in past year.

ANALYST RATINGS →

Goldman Sachs raises Viking Holdings price target

Today / 09:52

336

Goldman Sachs raises Viking Holdings price target

Goldman Sachs raises Viking Holdings price target to $95 on strong 2027 bookings and pricing growth.

ANALYST RATINGS →

Goldman Sachs Raises KGS Target to $88 on Power Growth

Today / 09:52

433

Goldman Sachs Raises KGS Target to $88 on Power Growth

Goldman Sachs raises Kodiak Gas Services price target to $88 on power growth. Strong earnings and expansion plans drive optimism.

ANALYST RATINGS →

Today / 08:53

541

Oppenheimer Downgrades Crescent BDC on Weak Returns

Oppenheimer downgrades Crescent BDC to Perform, cuts price target to $16. Stock at $11.99, weak Q1 results.

ANALYST RATINGS →

Today / 08:50

329

BofA Reiterates Buy on Alphabet Stock

BofA Securities reiterated a Buy rating on Alphabet stock ahead of its developer event. Get insights on AI announcements and stock performance.

ANALYST RATINGS →

Today / 08:32

977

Morgan Stanley Downgrades Aardvark Stock

Morgan Stanley downgrades Aardvark Therapeutics stock to Underweight, price target $3, after FDA clinical hold on ARD-101 over safety concerns.

ANALYST RATINGS →

Today / 08:22

238

Canaccord cuts Sangoma stock rating

Canaccord downgrades Sangoma stock rating due to weak results and pricing pressure. Price target cut to $4.

ANALYST RATINGS →

...